299. Cystic fibrosis Clinical trials / Disease details

Clinical trials : 1,695 / Drugs : 1,527 - (DrugBank : 268) / Drug target genes : 111 - Drug target pathways : 174

5 trials found

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT05523180 (ClinicalTrials.gov)	September 1, 2022	22/8/2022	A Study to Evaluate the Effect of Probiotic Supplement on Quality of Life	A Prospective, Randomized, Double-blinded, Placebo-controlled Study Evaluating the Safety and Impact of resB® Lung Support on Quality of Life in Adult Volunteers With Chronic Obstructive Pulmonary Disease or Non-cystic Fibrosis Bronchiectasis	Chronic Obstructive Pulmonary Disease;Non-cystic Fibrosis Bronchiectasis	Dietary Supplement: Probiotic;Other: Placebo	ResBiotic Nutrition, Inc.	Nutrasource Pharmaceutical and Nutraceutical Services, Inc.	Recruiting	18 Years	80 Years	All	50	N/A	United States
2	NCT01201434 (ClinicalTrials.gov)	October 2010	31/8/2010	Effect of Probiotics on Sputum Inflammation and Pulmonary Infections in Patients With Cystic Fibrosis	The Effect of Probiotics on Sputum Bacteria, Sputum Inflammation, and Pulmonary Infections in Patients With Cystic Fibrosis: A Double-blind Placebo-controlled Trial	Cystic Fibrosis	Dietary Supplement: Bio-25 probiotic	Sheba Medical Center	NULL	Terminated	5 Years	40 Years	Both	12	N/A	NULL
3	NCT01956916 (ClinicalTrials.gov)	October 2010	23/9/2013	Probiotics in Cystic Fibrosis	Effects of LGG Administration in Children With Cystic Fibrosis: A Randomized Controlled Trial	Cystic Fibrosis	Dietary Supplement: Lactobacillus rhamnosus GG;Dietary Supplement: placebo	Federico II University	NULL	Completed	2 Years	18 Years	Both	110	Phase 3	Italy
4	NCT01961661 (ClinicalTrials.gov)	September 2009	9/10/2013	Probiotics on Intestinal Inflammation in Cystic Fibrosis	Effect of Probiotics on Intestinal Inflammation and Microflora in Cystic Fibrosis: a Pilot Study	Cystic Fibrosis	Dietary Supplement: Lactobacillus rhamnosus GG;Dietary Supplement: placebo	Federico II University	NULL	Completed	2 Years	18 Years	Both	22	Phase 3	Italy
5	EUCTR2009-011289-27-IT (EUCTR)	22/04/2009	27/04/2009	Probiotics in Cystic Fibrosis - ND	Probiotics in Cystic Fibrosis - ND	Cystic Fibrosis Patients MedDRA version: 9.1;Level: SOC;Classification code 10017947	INN or Proposed INN: Lactic acid producing organisms	UNIVERSITA` DEGLI STUDI DI NAPOLI FEDERICO II	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes			Italy